Name (Synonyms) | Correlation | |
---|---|---|
drug1645 | Normal saline Wiki | 0.45 |
drug159 | Anakinra Wiki | 0.38 |
Name (Synonyms) | Correlation | |
---|---|---|
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The study aims to investigate the efficacy of extracorporeal CO2 removal for correction of hypercapnia in coronavirus disease 19 (COVID-19)-associated acute respiratory distress syndrome
Description: Delta partial pressure of carbon dioxide change during ECCO2R treatment
Measure: Delta change in arterial partial pressure of carbon dioxide during ECCO2R treatment Time: Up to 72 hoursDescription: Epinephrine and norepinephrine dose, mcg/kg/min
Measure: Change in vasopressor use during ECCO2R Time: Up to 72 hoursDescription: Assessment of changes in tidal volume
Measure: Assessment of changes in tidal volume during ECCO2R Time: Up to 72 hoursDescription: Assessment of changes in pH
Measure: Assessment of changes in pH during ECCO2R Time: Up to 72 hoursDescription: Assessment of changes in Positive End-Expiratory Pressure
Measure: Assessment of changes in Positive End-Expiratory Pressure during ECCO2R Time: Up to 72 hoursDescription: Adverse events directly related to ECCO2R are infection at the catheter site, hemorrhage at the cannulation site, air entry in the circuit.
Measure: Number of participants with adverse events directly related to ECCO2R Time: Up to 72 hoursDescription: Adverse events directly related to ECCO2R are clotting of the circuit.
Measure: Rate of technical adverse events related to ECCO2R Time: Up to 72 hoursDescription: Delta change in delta venous partial pressure of carbon dioxide before and after ECCO2R membrane
Measure: Delta change in venous partial pressure of carbon dioxide before and after ECCO2R membrane Time: Up to 72 hours